SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Essential Therapeutics (ETRX) formerly Microcide (MCDE
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: SemiBull who wrote (244)6/27/2000 11:44:00 PM
From: John O'Neill   of 415
 
All will be known in the fullness of time...the recent ride MCDE took may be frustrating...(got to $26)...but this market has warped stock value....IF mcde results go well in any of it's ventures, and they beat the competition in some areas...this one could really take off....a gamble.

If Vancomycin resistant strains combine with other bacteria, this problem will become a major, very major, national/world crisis overnight...remember, before antibiotics, 1/2 of fatalities resulted from bacterial infection
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News